Niederer Kraft Frey advises Idorsia on CHF 500m combined offering of new shares and convertible bonds
Niederer Kraft Frey advised Swiss biopharmaceutical company Idorsia Ltd on its offering of 11,912,000 new shares, corresponding to approximately 10% of its currently issued share capital, by way of an accelerated bookbuilding, and on its placement of CHF 200 million of senior unsecured convertible bonds due 2024.